NasdaqCM - Nasdaq Real Time Price USD

Genenta Science S.p.A. (GNTA)

2.9268 -0.0032 (-0.11%)
As of 11:03 AM EDT. Market Open.
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
11,732.9420
11,732.9420
11,043.9920
5,537.2730
5,590.2260
Operating Income
-11,732.9420
-11,732.9420
-11,043.9920
-5,537.2730
-5,590.2260
Net Non Operating Interest Income Expense
309.2530
309.2530
36.9850
-11.7160
-7.7540
Other Income Expense
-221.7660
-221.7660
2,529.2440
19.6570
5.9660
Pretax Income
-11,645.4550
-11,645.4550
-8,477.7630
-5,529.3320
-5,592.0140
Net Income Common Stockholders
-11,645.4550
-11,645.4550
-8,477.7630
-5,529.3320
-5,592.0140
Diluted NI Available to Com Stockholders
-11,645.4550
-11,645.4550
-8,477.7630
-5,529.3320
-5,592.0140
Basic EPS
-0.72
-0.64
-0.47
-0.37
-0.38
Diluted EPS
-0.72
-0.64
-0.47
-0.37
-0.38
Basic Average Shares
18,216.8580
18,216.9070
18,216.8580
15,083.8250
14,772.6100
Diluted Average Shares
18,216.8580
18,216.9070
18,216.8580
15,083.8250
14,772.6100
Total Operating Income as Reported
-11,732.9420
-11,732.9420
-11,043.9920
-5,687.2730
-5,590.2260
Total Expenses
11,732.9420
11,732.9420
11,043.9920
5,537.2730
5,590.2260
Net Income from Continuing & Discontinued Operation
-11,645.4550
-11,645.4550
-8,477.7630
-5,529.3320
-5,592.0140
Normalized Income
-11,428.5640
-11,428.5640
-10,764.4530
-5,529.3320
-5,592.0140
Interest Expense
--
--
--
11.7160
7.7540
Net Interest Income
309.2530
309.2530
36.9850
-11.7160
-7.7540
EBIT
-11,732.9420
-11,732.9420
-11,043.9920
-5,537.2730
-5,590.2260
EBITDA
-11,690.4890
-11,690.4890
-11,037.8520
-5,532.3840
-5,588.3260
Reconciled Depreciation
42.4530
42.4530
6.1400
4.8890
1.9000
Net Income from Continuing Operation Net Minority Interest
-11,645.4550
-11,645.4550
-8,477.7630
-5,529.3320
-5,592.0140
Total Unusual Items Excluding Goodwill
-216.8910
-216.8910
2,286.6900
--
--
Total Unusual Items
-216.8910
-216.8910
2,286.6900
--
--
Normalized EBITDA
-11,473.5980
-11,473.5980
-13,324.5420
-5,532.3840
-5,588.3260
12/31/2020 - 12/15/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

TELO Telomir Pharmaceuticals, Inc.
6.40
-5.04%
 
ANL Adlai Nortye Ltd.
12.71
-5.57%
 
FNCH Finch Therapeutics Group, Inc.
2.3200
+3.11%
 
ENZN Enzon Pharmaceuticals, Inc.
0.0835
-5.17%
 
PTIX Protagenic Therapeutics, Inc.
1.4700
+1.38%
 
CHRO Chromocell Therapeutics Corporation
1.5699
+4.66%
 
CMPX Compass Therapeutics, Inc.
1.4300
-3.38%
 
IPSC Century Therapeutics, Inc.
2.9000
-7.94%
 
BNTC Benitec Biopharma Inc.
6.93
+0.43%
 
NGNE Neurogene Inc.
29.88
+0.03%